Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence for the Detection of Central Retinal Disease and Non-mydriatic Glaucoma in the Context of Patients With Diabetes Mellitus in Primary Care: A Prospective Study Comparing the Diagnostic Capacity of an AI Algorithm

NCT04132401 is registered in ClinicalTrials.gov with Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina as lead sponsor.

NCT NCT04132401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04132401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence for the Detection of Central Retinal Disease and Non-mydriatic Glaucoma in the Context of Patients With Diabetes Mellitus in Primary Care: A Prospective Study Comparing the Diagnostic Capacity of an AI Algorithm
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
September 26, 2023
Enrollment
902 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, choroidal nevus, diabetic retinopathy, epiretinal membrane, glaucoma